FARE - Food Allergy Research & Education Logo

Future In Sight with Peter Kolchinsky

In this monthly series, Peter engages with equally sharp and unfiltered geniuses about the potential of solving big picture problems in our lifetimes.

Episode 7: Food Allergies & Early Intervention 

Guest: Ruchi Gupta, MD, MPH

December 10, 2021

In this episode, Peter & Dr. Ruchi will discuss the history of the medicalization of food, where we are, and hopes to change the future.  

Episode 6: Innovation in the Food and Beverage Industry 

Guest: Robert Earl, MPH, RDN, FAND 
Vice President of Regulatory Affairs at FARE

December 3, 2021

Join Peter and his guest Robert Earl, Vice President of Regulatory Affairs at FARE as they discuss the importance of working with government and regulatory leadership & food industry innovation.

Episode 5: The Microbiome

Guest: Nurry Hong, CEO at Pareto Bio 

September 2, 2021

In this episode, Nurry Hong and podcast host Peter Kolchinsky discuss the  microbiome, its importance, and future developments. 

Episode 4: Healthcare: Changing Things for the Better

Guest: Mariya Filopova, Serial Intrapreneur, Activated Patient, Former VP of Innovation at Anthem 

July 22, 2021

Join Peter and his guest,  Mariya Filipova, Serial Intrapreneur,  as they unpack healthcare needs, services and insurance from the patient perspective and how new technologies, innovation and processes can help transform these industries. 

About the Guest

As the Vice President of Innovation, Mariya led Anthem’s efforts in scaling emerging technologies and new business models to accelerate Anthem’s transformation to a digital-first enterprise.  

Prior to Anthem, Mariya drove the development of Deloitte’s Future of Work Center of Excellence, a portfolio of investments across the Americas,  APAC, and EMEA that used exponential technologies (e.g. blockchain, artificial intelligence) to redefine the future of work.

Mariya holds an MBA from Harvard Business School and a BA in Economics, summa cum laude, from Mount Holyoke College. She serves on the Board of Governors for the Harvard Business School Association of Boston. 

Episode 3: Tools for Food Allergy Management 

Guest: Kari Nadeau, MD, PhD

June 17, 2021

In this episode, Dr. Kari Nadeau and podcast host Peter Kolchinsky discuss a variety of topics including treatments, therapeutics, diagnostics, prevention, and healthcare.  Their conversation will  highlight the hope and promise that science has delivered for patients as well as opportunities of what’s to come. 

Episode 2: Defeating Food Allergies

Guest: Rob Reid, author and entrepreneur

May 20, 2021

The prevalence of food allergies in the U.S. is greater than it’s ever been before, roughly doubling every ten years. Diagnoses of anaphylactic food reactions have risen by 377 percent since 2007, according to recent FARE-commissioned data.

To address this concerning trend, Dr. Kari Nadeau, MD, PhD, the director of the Sean N. Parker Center for Allergy Research at Stanford University and FARE’s medical advisor for innovation, sat down for an interview with Rob Reid on the “After On” podcast to discuss this public health crisis and the groundbreaking research underway to develop new therapies and diagnostic tools.

Episode 1: Food Allergy Primer

Guest: Wayne Shreffler, MD, PhD, Massachusetts General Hospital

April 15, 2021

Join Peter Kolchinsky on his first episode of Future in Sight, a new podcast from FARE. In this episode Peter speaks with Dr. Wayne Shreffler, Director of the Food Allergy Center at Massachusetts General Hospital & Division Chief of Pediatric Allergy and Immunology at MassGeneral Hospital for Children. They will discuss the origins and history of food allergies, how we got to this point in history where 32 million Americans have life-threatening food allergies, and what the future holds for treatments, therapeutics and the next generation.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.